The Efficacy and Safety of Pulp Regeneration Induced by SHED Polymerization

StatusUnknown
PhaseNot applicable
Started

Record status This record was last updated August 28, 2023 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Aug 2023); last known: Not Yet Recruiting
  2. Start date: Jul 1, 2023 to Sep 1, 2023
    • Study title shortened, about 4 words
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Dental pulp necrosis is one of the most common pathological conditions that results in tooth loss. However, regeneration of functional dental pulp has proved difficult. Therefore, the investigators conduct a single-arm study to evaluate the efficacy and safety of pulp regeneration induced by SHED mixed with hyaluronic acid polymerization in patients with pulp necrosis of permanent teeth.
Trial Details
NCT Number NCT05728346
Lead Sponsor Fifth Affiliated Hospital of Guangzhou Medical University
Conditions
(from sponsor)		 Pulp Necroses
Related terms Dental Pulp Necrosis
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov